Diet drug maker agrees to $3.75 billion settlement.
SoRelle
R
R
D020372:Dexfenfluramine / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005277:Fenfluramine / Q000009:adverse effects*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D014481:United States
D005277:Fenfluramine; D020372:Dexfenfluramine